共 9 条
[1]
Hemorrhagic complications of anticoagutant treatment. Levine MN,Raskob CG,Landefeld S,et al. Chest . 2001
[2]
Inherited thrombophilia and fetal loss. Brenner B. Current Opinion in Hematology . 2000
[3]
Heparin and lowmolecular-weight heparin: mechanisms of action, pharmacokinetics,dosing, monitoring, efficacy, and safety. Hirsh J,Warkentin TE,Shaughnessy SG. et al. Chest . 2001
[4]
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. Gould MK,Dembitzer AD,Doyle RL,et al. Annals of Internal Medicine . 1999
[5]
Low-molecular-weight heparins. Weitz JI. The New England Journal of Medicine . 1997
[6]
Howwe diagnose and treat deep vein thrombosis. Hirsh J,Lee AY. Blood . 2002
[7]
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis, Warfarin Optimal Duration Italian Trial Investigators. Agnelli G,Prandoni P,Santamaria MG,et al. The New England Journal of Medicine . 2001
[8]
Managing oral anticoagulant therapy. Ansell J,Hirsh J,Dalen J,et al. Chest . 2001
[9]
Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Ginsberg JS,Hirsh J,Julian J,et al. Archives of Internal Medicine . 2001